Related Experiment Video
Updated: Jan 20, 2026

Spatiotemporal Control of Protein Activity through Optogenetic Allosteric Regulation
Published on: October 4, 2024
Interplay between c-Src and the APC/C co-activator Cdh1 regulates mammary tumorigenesis
Tao Han1, Shulong Jiang1,2,3, Hong Zheng4
1Department of Molecular Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
Abstract:
The Anaphase Promoting Complex (APC) coactivator Cdh1 drives proper cell cycle progression and is implicated in the suppression of tumorigenesis. However, it remains elusive how Cdh1 restrains cancer progression and how tumor cells escape the inhibition of Cdh1. Here we report that Cdh1 suppresses the kinase activity of c-Src in an APC-independent manner. Depleting Cdh1 accelerates breast cancer cell proliferation and cooperates with PTEN loss to promote breast tumor progression in mice. Hyperactive c-Src, on the other hand, reciprocally inhibits the ubiquitin E3 ligase activity of APCCdh1 through direct phosphorylation of Cdh1 at its N-terminus, which disrupts the interaction between Cdh1 and the APC core complex. Furthermore, pharmacological inhibition of c-Src restores APCCdh1 tumor suppressor function to repress a panel of APCCdh1 oncogenic substrates. Our findings reveal a reciprocal feedback circuit of Cdh1 and c-Src in the crosstalk between the cell cycle machinery and the c-Src signaling pathway.
Insights
Cdh1 restrains breast cancer by suppressing c-Src kinase activity. Disrupting this feedback loop, through c-Src inhibition, restores Cdh1
Area of Science:
- Cell Biology
- Cancer Research
- Molecular Oncology
Background:
- The Anaphase Promoting Complex (APC) coactivator Cdh1 is crucial for cell cycle regulation and tumor suppression.
- Mechanisms by which Cdh1 inhibits cancer progression and how cancer cells evade Cdh1's control are not fully understood.
Purpose of the Study:
- To elucidate the role of Cdh1 in suppressing cancer progression.
- To investigate the interplay between Cdh1 and the c-Src signaling pathway in breast cancer.
Main Methods:
- Investigated the APC-independent function of Cdh1.
- Utilized mouse models of breast cancer with Cdh1 depletion and PTEN loss.
- Examined the effect of c-Src activity on APCCdh1 function via phosphorylation.
- Assessed the impact of pharmacological c-Src inhibition on tumor suppressor activity.
Main Results:
- Cdh1 suppresses c-Src kinase activity independently of the APC.
- Cdh1 depletion accelerates breast cancer cell proliferation and tumor progression, especially when combined with PTEN loss.
- Hyperactive c-Src phosphorylates Cdh1, inhibiting APCCdh1 ligase activity and disrupting Cdh1-APC complex formation.
- Pharmacological inhibition of c-Src restores APCCdh1 tumor suppressor function against oncogenic substrates.
Conclusions:
- A reciprocal feedback circuit exists between Cdh1 and c-Src, linking cell cycle control and c-Src signaling.
- Targeting c-Src can restore the tumor-suppressive function of APCCdh1, offering a potential therapeutic strategy for breast cancer.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Enteric Nervous System: Regulation of GI Motor Activity
During periods of fasting, the ENS initiates the migrating myoelectric complex, a...
GPCRs Regulate Adenylyl Cylase Activity
GTPases and their Regulation
Large G-proteins,...
The Mammary Glands
Each breast features a pigmented projection known as the nipple, through which milk emerges via closely spaced openings of ducts, referred to as lactiferous ducts. Surrounding the nipple is a circular pigmented area of skin named the areola, which appears rough due to...
Epigenetic Regulation

